Abstract:In the drug discovery paradigm, the evaluation of absorption, distribution, metabolism, and excretion (ADME) and toxicity properties of new chemical entities is one of the most critical issues, which is a time-consuming process, immensely expensive, and poses formidable challenges in pharmaceutical R&D. In recent years, emerging technologies like artificial intelligence (AI), big data, and cloud technologies have garnered great attention to predict the ADME and toxicity of molecules. Currently, the blend of quantum computation and machine learning has attracted considerable attention in almost every field ranging from chemistry to biomedicine and several engineering disciplines as well. Quantum computers have the potential to bring advances in high-throughput experimental techniques and in screening billions of molecules by reducing development costs and time associated with the drug discovery process. Motivated by the efficiency of quantum kernel methods, we proposed a quantum machine learning (QML) framework consisting of a classical support vector classifier algorithm with a kernel-based quantum classifier. To demonstrate the feasibility of the proposed QML framework, the simplified molecular input line entry system (SMILES) notation-based string kernel, combined with a quantum support vector classifier, is used for the evaluation of chemical/drug ADME-Tox properties. The proposed quantum machine learning framework is validated and assessed via large-scale simulations. Based on our results from numerical simulations, the quantum model achieved the best performance as compared to classical counterparts in terms of the area under the curve of the receiver operating characteristic curve (AUC ROC; 0.80-0.95) for predicting outcomes on ADME-Tox data sets for small molecules, with a different number of features. The deployment of the proposed framework in the pharmaceutical industry would be extremely valuable in making the best decisions possible.

Quantum probability ranking principle for ligand-based virtual screening

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

Quantum Chemical Approaches in Structure-Based Virtual Screening and Lead Optimization

Quantum machine learning framework for virtual screening in drug discovery: a prospective quantum advantage

3D-Pharma, A Ligand-based Virtual Screening tool using 3D Pharmacophore Fingerprints

When drug discovery meets web search: Learning to Rank for ligand-based virtual screening

One size does not fit all: revising traditional paradigms for QSAR-based virtual screenings.

Quantum molecular docking with quantum-inspired algorithm

Quantum Molecular Docking with a Quantum-Inspired Algorithm

Unlocking the Potential of Quantum Machine Learning to Advance Drug Discovery

The role of quantum mechanics in structure-based drug design.

Quantum Machine Learning Predicting ADME-Tox Properties in Drug Discovery

Quantum Computational Quantification of Protein-Ligand Interactions

A Novel and Efficient Ligand-Based Virtual Screening Approach Using the HWZ Scoring Function and an Enhanced Shape-Density Model.

Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design

Implementation of The Future of Drug Discovery: QuantumBased Machine Learning Simulation (QMLS)

Quantum Chemistry in a Pocket: A Multifaceted Tool to Link Structure and Activity

Machine Learning Guided AQFEP: A Fast and Efficient Absolute Free Energy Perturbation Solution for Virtual Screening

Virtual Screening, Molecular Docking and QSAR Studies in Drug Discovery and Development Programme

Molecular docking via quantum approximate optimization algorithm

Comparative Analysis of QSAR‐based Vs. Chemical Similarity Based Predictors of GPCRs Binding Affinity